Abstracts tagged "Ankylosing spondylitis (AS) and outcome measures"

Abstract Number: 680 • 2015 ACR/ARHP Annual Meeting
Variability over Time in Patient-Reported Outcome Measures in Patients with Ankylosing Spondylitis
Ivette Essers^1,2, Matthias Busch², Annelies Boonen^1,3, Sofia Ramiro⁴, Désirée van der Heijde⁵, Robert B.M. Landewé^6,7 and Astrid van Tubergen^1,2, ¹School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, ²Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Maastricht University Medical Center, Maastricht, Netherlands, ⁴Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁵Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands, ⁶Rheumatology, Atrium Medical Center, Heerlen, Netherlands, ⁷Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands
Background/Purpose: The BASDAI, BAS-G, and a VAS for spinal pain (VAS-pain) are used to assess disease outcomes in AS. The intervals with which these patient-reported…
Abstract Number: 2600 • 2014 ACR/ARHP Annual Meeting
Gender-Attributable Differences in Outcome of Ankylosing Spondylitis: Long-Term Results from the Outcome in Ankylosing Spondylitis International Study
Casper Webers¹, Ivette Essers^1,2, Sofia Ramiro^3,4, Carmen Stolwijk^1,2, Robert Landewé⁵, Désirée van der Heijde⁶, Filip van Den Bosch⁷, Maxime Dougados^8,9 and Astrid van Tubergen^1,10, ¹Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, ³Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center/University of Amsterdam, Amsterdam, Netherlands, ⁴Rheumatology, Hospital Garcia de Orta, Almada, Portugal, ⁵Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, ⁸Paris-Descartes University, Paris, France, ⁹Rheumatology, Hopital Cochin, Descartes University, Paris, France, ¹⁰Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands
Background/Purpose: In ankylosing spondylitis (AS), gender-attributable differences have been reported with respect to clinical and radiographic outcome. However, longitudinal studies exploring gender-attributable differences in the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].